Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11667702 Stable aqueous formulations of aflibercept

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Coherus BioSciences
Coherus BioSciences
0
Date Filed
March 8, 2019
0
Date of Patent
June 6, 2023
0
Patent Applicant
Coherus BioSciences
Coherus BioSciences
0
Patent Application Number
16297387
0
Patent Citations
‌
US Patent 8349321 Immunoglobulin formulation and method of preparation thereof
0
‌
US Patent 8481046 VEGF antagonist formulations for intravitreal administration
0
‌
US Patent 8802107 VEGF antagonist formulations for intravitreal administration
0
‌
US Patent 9446134 Stabilizing alkylglycoside compositions and methods thereof
0
‌
US Patent 9580480 Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
0
‌
US Patent 11426446 Stable aqueous formulations of aflibercept
0
‌
US Patent 10046025 Stabilizing alkylglycoside compositions and methods thereof
0
‌
US Patent 7608261 VEGF antagonist formulations suitable for intravitreal administration
0
‌
US Patent 7807164 Lyophilized VEGF antagonist formulations for intravitreal administration
0
‌
US Patent 8084022 Stabilizing alkylglycoside compositions and methods thereof
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11667702
0
Patent Primary Examiner
‌
Yunsoo Kim
0

Find more entities like US Patent 11667702 Stable aqueous formulations of aflibercept

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.